Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02575430 · ClinicalTrials.gov registry record
Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT
A clinical trial, sponsored by QLT.
- Completed
- Registry status
- 59
- Enrollment target
NCT02575430 is a clinical trial that has completed, run by QLT. The registered enrollment target is 59 participants.
The verdict
NCT02575430 has completed, sponsored by QLT.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
Study Summary
To evaluate the natural history of visual function in subjects with IRD phenotypically diagnosed as Leber congenital amaurosis (LCA) or retinitis pigmentosa (RP) caused by RPE65 or LRAT gene mutations.
Interventions
- OTHER No treatment: retrospective chart review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02575430
The ClinicalTrials.gov registry entry for NCT02575430 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is QLT, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No treatment: retrospective chart review is the first listed.
NCT02575430 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02575430 about?
NCT02575430 is a clinical study titled "Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT". To evaluate the natural history of visual function in subjects with IRD phenotypically diagnosed as Leber congenital amaurosis (LCA) or retinitis pigmentosa (RP) caused by RPE65 or LRAT gene mutations.
What is the current status of trial NCT02575430?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2015-12. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02575430?
The interventions under investigation include: No treatment: retrospective chart review (OTHER).
Who is sponsoring clinical trial NCT02575430?
This trial is sponsored by QLT, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.